Header Logo

Connection

LARRY LIPSHULTZ to Hypogonadism

Back to Details
This is a "connection" page, showing publications LARRY LIPSHULTZ has written about Hypogonadism.
LARRY LIPSHULTZ
Connection Strength
12.210
Hypogonadism
  1. Is treatment of hypogonadism safe for men after a solid organ transplant? Results from a retrospective controlled cohort study. Int J Impot Res. 2022 Jan; 34(1):50-54.
    View in: PubMed
    Score: 0.521
  2. Treatment of Estrogen Levels in the Management of Hypogonadism: An Anonymous Survey of ISSM Members. Urology. 2020 05; 139:104-109.
    View in: PubMed
    Score: 0.497
  3. Increased Risk of Hypogonadal Symptoms in Shift Workers With Shift Work Sleep Disorder. Urology. 2020 04; 138:52-59.
    View in: PubMed
    Score: 0.494
  4. Does Solid Organ Transplantation Affect Male Reproduction? Eur Urol Focus. 2018 04; 4(3):307-310.
    View in: PubMed
    Score: 0.451
  5. Testosterone therapy improves well being and psychological health. Curr Opin Urol. 2017 Nov; 27(6):519-524.
    View in: PubMed
    Score: 0.425
  6. Growth Hormone Secretagogue Treatment in Hypogonadal Men Raises Serum Insulin-Like Growth Factor-1 Levels. Am J Mens Health. 2017 Nov; 11(6):1752-1757.
    View in: PubMed
    Score: 0.419
  7. Poor Sleep Quality Predicts Hypogonadal Symptoms and Sexual Dysfunction in Male Nonstandard Shift Workers. Urology. 2017 04; 102:121-125.
    View in: PubMed
    Score: 0.400
  8. Age and duration of testosterone therapy predict time to return of sperm count after human chorionic gonadotropin therapy. Fertil Steril. 2017 02; 107(2):351-357.e1.
    View in: PubMed
    Score: 0.398
  9. Testosterone and Male Infertility. Urol Clin North Am. 2016 May; 43(2):195-202.
    View in: PubMed
    Score: 0.380
  10. Dietary Adjuncts for Improving Testosterone Levels in Hypogonadal Males. Am J Mens Health. 2016 11; 10(6):NP109-NP117.
    View in: PubMed
    Score: 0.364
  11. Association of Free Testosterone With Hypogonadal Symptoms in Men With Near-normal Total Testosterone Levels. Urology. 2015 Aug; 86(2):287-90.
    View in: PubMed
    Score: 0.363
  12. Words of Wisdom. Re: incidence of prostate cancer in hypogonadal men receiving testosterone therapy: observations from 5-year median followup of 3 registries. Eur Urol. 2015 Jun; 67(6):1186-7.
    View in: PubMed
    Score: 0.359
  13. Hypogonadal symptoms in young men are associated with a serum total testosterone threshold of 400 ng/dL. BJU Int. 2015 Jul; 116(1):142-6.
    View in: PubMed
    Score: 0.354
  14. Testosterone therapy and cancer risk. BJU Int. 2015 Feb; 115(2):317-21.
    View in: PubMed
    Score: 0.344
  15. Hypogonadal symptoms are associated with different serum testosterone thresholds in middle-aged and elderly men. Urology. 2014 Dec; 84(6):1378-82.
    View in: PubMed
    Score: 0.343
  16. Word of wisdom. Re: testosterone lab testing and initiation in the United kingdom and the United States, 2000 to 2011. Eur Urol. 2014 Oct; 66(4):786-7.
    View in: PubMed
    Score: 0.343
  17. Effect of testosterone supplementation on symptoms in men with hypogonadism. Eur Urol. 2015 Jan; 67(1):176-177.
    View in: PubMed
    Score: 0.342
  18. Testosterone therapy and mortality risk. Int J Impot Res. 2015 Mar-Apr; 27(2):46-8.
    View in: PubMed
    Score: 0.339
  19. The safety of testosterone supplementation therapy in prostate cancer. Nat Rev Urol. 2014 Sep; 11(9):526-30.
    View in: PubMed
    Score: 0.339
  20. A positive role for anabolic androgenic steroids: preventing metabolic syndrome and type 2 diabetes mellitus. Fertil Steril. 2014 Jul; 102(1):e5.
    View in: PubMed
    Score: 0.335
  21. Testosterone supplementation versus clomiphene citrate for hypogonadism: an age matched comparison of satisfaction and efficacy. J Urol. 2014 Sep; 192(3):875-9.
    View in: PubMed
    Score: 0.331
  22. Patient satisfaction with testosterone replacement therapies: the reasons behind the choices. J Sex Med. 2014 Feb; 11(2):553-62.
    View in: PubMed
    Score: 0.322
  23. Factors influencing patient decisions to initiate and discontinue subcutaneous testosterone pellets (Testopel) for treatment of hypogonadism. J Sex Med. 2013 Sep; 10(9):2326-33.
    View in: PubMed
    Score: 0.316
  24. Anabolic steroid induced hypogonadism in young men. J Urol. 2013 Dec; 190(6):2200-5.
    View in: PubMed
    Score: 0.313
  25. Concomitant intramuscular human chorionic gonadotropin preserves spermatogenesis in men undergoing testosterone replacement therapy. J Urol. 2013 Feb; 189(2):647-50.
    View in: PubMed
    Score: 0.303
  26. The treatment of hypogonadism in?men of reproductive age. Fertil Steril. 2013 Mar 01; 99(3):718-24.
    View in: PubMed
    Score: 0.303
  27. Testosterone replacement therapy following radical prostatectomy. J Sex Med. 2009 Apr; 6(4):1165-1170.
    View in: PubMed
    Score: 0.231
  28. Correlation between simultaneous PSA and serum testosterone concentrations among eugonadal, untreated hypogonadal and hypogonadal men receiving testosterone replacement therapy. Int J Impot Res. 2008 Nov-Dec; 20(6):561-5.
    View in: PubMed
    Score: 0.227
  29. The role of testosterone replacement therapy following radical prostatectomy. Urol Clin North Am. 2007 Nov; 34(4):549-53, vi.
    View in: PubMed
    Score: 0.212
  30. Efficacy of changing testosterone gel preparations (Androgel or Testim) among suboptimally responsive hypogonadal men. Int J Impot Res. 2008 Mar-Apr; 20(2):213-7.
    View in: PubMed
    Score: 0.211
  31. Microsurgical varicocelectomy: novel applications to optimize patient outcomes. Fertil Steril. 2019 10; 112(4):632-639.
    View in: PubMed
    Score: 0.121
  32. Human Chorionic Gonadotropin monotherapy for the treatment of hypogonadal symptoms in men with total testosterone > 300 ng/dL. Int Braz J Urol. 2019 Sep-Oct; 45(5):1008-1012.
    View in: PubMed
    Score: 0.121
  33. Selective Androgen Receptor Modulators: Current Knowledge and Clinical Applications. Sex Med Rev. 2019 01; 7(1):84-94.
    View in: PubMed
    Score: 0.114
  34. Iron and a Man's Reproductive Health: the Good, the Bad, and the Ugly. Curr Urol Rep. 2018 Jun 01; 19(8):60.
    View in: PubMed
    Score: 0.111
  35. The Effect of Shift Work on Urogenital Disease: a Systematic Review. Curr Urol Rep. 2018 May 28; 19(8):57.
    View in: PubMed
    Score: 0.111
  36. Effects of Testosterone Replacement Therapy on Lower Urinary Tract Symptoms: A Systematic Review and Meta-analysis. Eur Urol. 2016 06; 69(6):1083-90.
    View in: PubMed
    Score: 0.094
  37. Association Between Testosterone Supplementation Therapy and Thrombotic Events in Elderly Men. Urology. 2015 Aug; 86(2):283-5.
    View in: PubMed
    Score: 0.091
  38. Current state of practice regarding testosterone supplementation therapy in men with prostate cancer. Steroids. 2014 Nov; 89:27-32.
    View in: PubMed
    Score: 0.085
  39. Enclomiphene citrate stimulates testosterone production while preventing oligospermia: a?randomized phase II clinical trial comparing topical testosterone. Fertil Steril. 2014 Sep; 102(3):720-7.
    View in: PubMed
    Score: 0.085
  40. Anabolic steroid-induced hypogonadism: diagnosis and treatment. Fertil Steril. 2014 May; 101(5):1271-9.
    View in: PubMed
    Score: 0.083
  41. Elevated serum estradiol is associated with higher libido in men on testosterone supplementation therapy. Eur Urol. 2014 Jun; 65(6):1224-5.
    View in: PubMed
    Score: 0.082
  42. Testosterone replacement therapy in patients with prostate cancer after radical prostatectomy. J Urol. 2013 Aug; 190(2):639-44.
    View in: PubMed
    Score: 0.077
  43. The evidence for seasonal variations of testosterone in men. Maturitas. 2013 Mar; 74(3):208-12.
    View in: PubMed
    Score: 0.076
  44. Testosterone replacement therapy in the setting of prostate cancer treated with radiation. Int J Impot Res. 2013 Jan; 25(1):24-8.
    View in: PubMed
    Score: 0.074
  45. Pharmacokinetic evaluation and dosing of subcutaneous testosterone pellets. J Androl. 2012 Sep-Oct; 33(5):927-37.
    View in: PubMed
    Score: 0.072
  46. Subcutaneous implantable testosterone pellets overcome noncompliance in adolescents with Klinefelter syndrome. J Androl. 2012 Jul-Aug; 33(4):570-3.
    View in: PubMed
    Score: 0.070
  47. Anabolic steroid-induced hypogonadotropic hypogonadism. Am J Sports Med. 1990 Jul-Aug; 18(4):429-31.
    View in: PubMed
    Score: 0.064
  48. The quantitative ADAM questionnaire: a new tool in quantifying the severity of hypogonadism. Int J Impot Res. 2010 Jan-Feb; 22(1):20-4.
    View in: PubMed
    Score: 0.060
  49. The Relationship Between Shift Work and Men's Health. Sex Med Rev. 2018 07; 6(3):446-456.
    View in: PubMed
    Score: 0.027
  50. Medical treatment of male infertility. Urol Clin North Am. 1987 May; 14(2):307-22.
    View in: PubMed
    Score: 0.013
  51. Experience with 425 subfertile male patients. J Urol. 1978 Apr; 119(4):507-10.
    View in: PubMed
    Score: 0.002
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.